Medical Developments International (ASX:MVP) Retained Earnings: A$-62.99 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:MVP Medical Developments International Ltd ASX:MVP
54 GF Score
Price A$0.41
GF Value A$0.65
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medical Developments International Retained Earnings?

Medical Developments International ASX:MVP +1.23% 54 Retained Earnings is A$-62.99 Mil as of Dec. 2025. GuruFocus rates ASX:MVP with a GF Score™ of 54/100 and a GF Value™ of A$0.65 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Medical Developments International's retained earnings for the quarter that ended in Dec. 2025 was A$-62.99 Mil.

Medical Developments International's quarterly retained earnings declined from Dec. 2024 (A$-62.56 Mil) to Jun. 2025 (A$-62.77 Mil) and declined from Jun. 2025 (A$-62.77 Mil) to Dec. 2025 (A$-62.99 Mil).

Medical Developments International's annual retained earnings declined from Jun. 2023 (A$-30.15 Mil) to Jun. 2024 (A$-62.86 Mil) but then increased from Jun. 2024 (A$-62.86 Mil) to Jun. 2025 (A$-62.77 Mil).


Medical Developments International  (ASX:MVP) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Medical Developments International Retained Earnings Historical Data

* Premium members only.

The historical data trend for Medical Developments International's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Developments International Retained Earnings Chart

Medical Developments International Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.14 -24.55 -30.15 -62.86 -62.77

Medical Developments International Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.81 -62.86 -62.56 -62.77 -62.99
ASX:MVP
54GF Score
Medical Developments International Ltd ASX:MVP
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Developments International Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of A$-62.99 Mil mean?
Medical Developments International (ASX:MVP) has a Retained Earnings of A$-62.99 Mil as of Dec. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on Medical Developments International and its competitors.
Is Medical Developments International's Retained Earnings too high?
Medical Developments International's current Retained Earnings is A$-62.99 Mil. Overall, Medical Developments International has a GF Score™ of 54/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Developments International's Retained Earnings compare to ZTS and UTHR?
Medical Developments International's Retained Earnings of A$-62.99 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Drug Manufacturers company?
A good Retained Earnings depends on the Drug Manufacturers industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Medical Developments International and its competitors. Medical Developments International's current Retained Earnings is A$-62.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Developments International stock overvalued right now?
Based on GuruFocus' analysis, Medical Developments International (ASX:MVP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.65, compared to a current price of A$0.41 — trading 36.9% below its estimated fair value. The current Retained Earnings is A$-62.99 Mil. Medical Developments International's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Medical Developments International (ASX:MVP), the current Retained Earnings is A$-62.99 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Developments International (ASX:MVP) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Developments International stock appears to be undervalued. The current stock price of A$0.41 is trading 36.9% below its estimated GF Value™ of A$0.65. GuruFocus considers Medical Developments International to be Significantly Undervalued.

Key valuation signals for ASX:MVP:

  • Retained Earnings: A$-62.99 Mil
  • GF Value™: A$0.65 vs. price of A$0.41 (36.9% below fair value)
  • GF Score™: 54/100 with 2 warning signs

No single metric tells the full story. See the ASX:MVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medical Developments International Business Description

Other Exchanges MDDVF:USAM5D:Germany
Address 4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
54GF Score

Get the complete analysis for ASX:MVP

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.41
Price
A$0.65
GF Value